Ronald E See
Overview
Explore the profile of Ronald E See including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
4618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
See R, Eusebio B, Agnew D, Heatwole M
Psychiatry Res
. 2021 Jun;
302:114053.
PMID: 34144510
Steroid hormones may serve as potential biomarkers of treatment response for major depressive disorder (MDD). Here, we assessed salivary levels of cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate (DHEA-S), as well...
2.
Feltenstein M, See R, Fuchs R
Cold Spring Harb Perspect Med
. 2020 Mar;
11(4).
PMID: 32205414
Drug addiction is a chronic relapsing disorder, and a significant amount of research has been devoted to understand the factors that contribute to the development, loss of control, and persistence...
3.
Leong K, Freeman L, Berini C, Ghee S, See R, Reichel C
Int J Neuropsychopharmacol
. 2017 Oct;
20(10):844-854.
PMID: 28977525
Background: Oxytocin may be a possible treatment for multiple neuropsychiatric disorders, including cocaine addiction. Little is known about the site-specific effects of oxytocin on various drug addiction-related brain regions. Furthermore,...
4.
Cox B, Bentzley B, Regen-Tuero H, See R, Reichel C, Aston-Jones G
Biol Psychiatry
. 2017 Jan;
81(11):949-958.
PMID: 28110822
Background: Evidence indicates that oxytocin, an endogenous peptide well known for its role in social behaviors, childbirth, and lactation, is a promising addiction pharmacotherapy. We employed a within-session behavioral-economic (BE)...
5.
Bernheim A, See R, Reichel C
Neurosci Biobehav Rev
. 2016 Jul;
69:36-48.
PMID: 27450578
Methamphetamine (meth) is one of the most abused substances worldwide. Chronic use has been associated with repeated relapse episodes that may be exacerbated by cognitive impairments during drug abstinence. Growing...
6.
Malcolm R, Myrick H, Li X, Henderson S, Brady K, George M, et al.
J Drug Abuse
. 2016 Jun;
2(1).
PMID: 27314105
Background: Neuroimaging of drug-associated cue presentations has aided in understanding the neurobiological substrates of craving and relapse for cocaine, alcohol, and nicotine. However, imaging of cue-reactivity in methamphetamine addiction has...
7.
Taheri S, Xun Z, See R, Joseph J, Reichel C
Brain Res
. 2016 Apr;
1642:497-504.
PMID: 27103569
Background: Neuroimaging studies in psychostimulant addicts have reported functional neural activity changes in brain regions involved in relapse. However, the difference between the effects of the psychostimulants methamphetamine and cocaine...
8.
Cox B, Cope Z, Parsegian A, Floresco S, Aston-Jones G, See R
Psychopharmacology (Berl)
. 2016 Apr;
233(12):2319-27.
PMID: 27037939
Rationale: Methamphetamine (meth) addiction is a chronically relapsing disorder that often produces persistent cognitive deficits. These include decreased cognitive flexibility, which may prevent meth addicts from altering their habitual drug...
9.
Leong K, Zhou L, Ghee S, See R, Reichel C
Exp Clin Psychopharmacol
. 2015 Nov;
24(1):55-64.
PMID: 26523890
Oxytocin has been shown to decrease cocaine taking and seeking in male rats, suggesting potential treatment efficacy for drug addiction. In the present study, we extended these findings to the...
10.
Scofield M, Trantham-Davidson H, Schwendt M, Leong K, Peters J, See R, et al.
Neuropsychopharmacology
. 2015 Apr;
40(11):2526-35.
PMID: 25865928
Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in...